PET Imaging of Fibroblast Activation Protein in Various Cancers Using [18F]AlF‑NOTA‑FAPI‑04: Comparison with 18F-FDG in a Single-Center, Prospective Study
Academic Radiology · 2024-10 · 31 (10) · 4107-4118
DOI: 10.1016/j.acra.2024.04.017 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Academic Radiology, 2024-10. Verfasst von Liping Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of PET-CT, Harbin Medical University Cancer Hospital, Harbin, China. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Radiopharmaceuticals, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Harbin Medical University Cancer Hospital, Jiangsu Provincial Key Research and Development Program, Heilongjiang Province Science and Technology Department.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: Targeting fibroblast-activation protein is a newer diagnostic approach for the visualization of tumor stroma, and a novel aluminum-[18F] fluoride (Al18F)-labeled fibroblast-activation protein inhibitor-4 (FAPI-04), hereafter [18F] AlF-NOTA-FAPI-04, presents a promising alternative to gallium 68 (68Ga)-labeled FAPI owing to its relatively longer half-life. This study sought to evaluate the clinical usefulness of [18F] AlF-NOTA-FAPI-04 PET/CT for the diagnosis of various types of cancer, compared to [18F] FDG PET/CT. MATERIALS AND METHODS: In this prospective study conducted from October 2021 to January 2024, a total of 148 patients with 16 different tumor entities underwent contemporaneous 18F-FDG and 18F-FAPI-04 PET/CT either for an initial assessment or for recurrence detection. Uptake of 18F-FDG and 18F-FAPI-04 was quantified by the maximum standard uptake value (SUV max). Diagnostic sensitivity, specificity, and accuracy were compared by using the McNemar test between these two imaging agents. RESULTS: 18F-FAPI-04 PET/CT could clearly depict 16 different types of cancer with excellent image contrast, thereby leading to a higher detection rate of primary tumors than did 18F-FDG PET/CT (98.06% vs. 81.55%, P<0.001). In per-lymph node analysis, the sensitivity, specificity, and accuracy in the diagnosis of metastatic lymph nodes were 92.44%, 90.44%, and 91.56%, respectively, which was much higher than that 18F-FDG PET/CT (80.23%, 79.41%, and 79.87%, respectively). Meanwhile, 18F-FAPI-04 PET/CT outperformed 18F-FDG PET/CT in identifying more suspected distant metastases (86.57% vs. 74.13%, P<0.001). Furthermore, 18F-FAPI-04 PET/CT upgraded tumor staging in 36/101 patients (35.6%), and detected tumor recurrence or metastases in 43/47 patients (91.49%). CONCLUSION: Our findings demonstrated that primary and metastatic lesions in patients with various types of malignant tumors are well-visualized on 18F-FAPI-04 PET/CT, which exhibited a superior diagnostic performance than 18F-FDG PET/CT. Moreover, 18F-FAPI-04 PET/CT is a promising tool for tumor staging and follow-up of various malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of PET-CT, Harbin Medical University Cancer Hospital, Harbin, China.
- School of Nuclear Science and Technology, University of South China, Hunan, China.
- Department of Physical Diagnostics, Heilongjiang Provincial Hospital, Harbin, China.
- Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China.
- Department of PET-CT, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: wangkezheng9954001@163.com.
Förderung
- Harbin Medical University Cancer Hospital
- Jiangsu Provincial Key Research and Development Program
- Heilongjiang Province Science and Technology Department
Zitieren
APA
Yang, L., Cheng, L., Xu, Y., Ding, H., Gao, X., Chang, Z., & Wang, K. (2024). PET Imaging of Fibroblast Activation Protein in Various Cancers Using [18F]AlF‑NOTA‑FAPI‑04: Comparison with 18F-FDG in a Single-Center, Prospective Study. Academic Radiology, 31(10), 4107-4118. https://doi.org/10.1016/j.acra.2024.04.017
Vancouver
Yang L, Cheng L, Xu Y, Ding H, Gao X, Chang Z, et al. PET Imaging of Fibroblast Activation Protein in Various Cancers Using [18F]AlF‑NOTA‑FAPI‑04: Comparison with 18F-FDG in a Single-Center, Prospective Study. Academic Radiology. 2024;31(10):4107-4118. doi:10.1016/j.acra.2024.04.017
BibTeX
@article{Yang2024,
author = {Yang, Liping and Cheng, Liang and Xu, Yuchao and Ding, Hongchao and Gao, Xing and Chang, Zhengsong and Wang, Kezheng},
title = {PET Imaging of Fibroblast Activation Protein in Various Cancers Using [18F]AlF‑NOTA‑FAPI‑04: Comparison with 18F-FDG in a Single-Center, Prospective Study},
journal = {Academic Radiology},
year = {2024},
volume = {31},
number = {10},
pages = {4107--4118},
doi = {10.1016/j.acra.2024.04.017}
}
EUVIMED